Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anastasios Angelou

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Anticancer Research|November 7, 2018
Combined Hepatic Resection and Radio-frequency Ablation for Patients with Colorectal Cancer Liver Metastasis: A Viable Option for Patients with a Large Number of TumorsToshiro Masuda, Georgios Antonios Margonis, Nikolaos Andreatos, et al.
Anticancer Research|September 29, 2020
The Interplay Between Innate Immunity (TLR-4) and sCD40L in the Context of an Animal Model of Colitis-associated CancerAnastasios Angelou, Apostolos E Papalois, Efstathios Antoniou, et al.
Anticancer Research|December 8, 2020
Animal Models for the Calculation of Circulating Tumor Cells for Experimental DemonstrationNikolaos Garmpis, Christos Damaskos, Anastasios Angelou, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|April 14, 2019
KRAS mutational status impacts pathologic response to pre-hepatectomy chemotherapy: a study from the International Genetic Consortium for Liver MetastasesGeorgios A Margonis, Neda Amini, Nikolaos Andreatos, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|October 6, 2021
Mutant KRAS as a prognostic biomarker after hepatectomy for rectal cancer metastases: Does the primary disease site matter?Neda Amini, Nikolaos Andreatos, Georgios Antonios Margonis, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Anticancer Research|November 7, 2018
Combined Hepatic Resection and Radio-frequency Ablation for Patients with Colorectal Cancer Liver Metastasis: A Viable Option for Patients with a Large Number of TumorsToshiro Masuda, Georgios Antonios Margonis, Nikolaos Andreatos, et al.
Anticancer Research|September 29, 2020
The Interplay Between Innate Immunity (TLR-4) and sCD40L in the Context of an Animal Model of Colitis-associated CancerAnastasios Angelou, Apostolos E Papalois, Efstathios Antoniou, et al.
Anticancer Research|December 8, 2020
Animal Models for the Calculation of Circulating Tumor Cells for Experimental DemonstrationNikolaos Garmpis, Christos Damaskos, Anastasios Angelou, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|April 14, 2019
KRAS mutational status impacts pathologic response to pre-hepatectomy chemotherapy: a study from the International Genetic Consortium for Liver MetastasesGeorgios A Margonis, Neda Amini, Nikolaos Andreatos, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|October 6, 2021
Mutant KRAS as a prognostic biomarker after hepatectomy for rectal cancer metastases: Does the primary disease site matter?Neda Amini, Nikolaos Andreatos, Georgios Antonios Margonis, et al.
Pageof 3